CJC-1295 with DAC

FDA APPROVAL PENDING

Well Studied

Weight

Growth

Weight

CJC-1295 with DAC

Growth

Amino acid sequence

29

Amino acids

3367.9da

Molecular weight

Peptide

Type

Modified growth hormone releasing hormone engineered for extended duration via albumin-binding technology. DAC binds to albumin, extending half-life and providing continuous GHRH receptor stimulation.

Top researched benefits

Overview of CJC-1295 with DAC

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation.

Growth Hormone

  • Continuous growth hormone release for 6-8 days per injection.
  • Significantly elevates IGF-1 levels for extended periods.
  • Weekly dosing ideal for simple administration.

Body Composition

  • Continuous GH elevation promotes lipolysis and fat metabolism.
  • Sustained anabolic environment supports muscle protein synthesis.

Antiaging

  • Accelerated healing and recovery from exercise or injury.

Storage

Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days

Frequency

Once or twice weekly (e.g., Monday/Thursday for split dosing)

Typical Dose

1-2mg weekly

Cycle Duration

8-12 weeks

Chemical Makeup

Key benefits

Convenient weekly dosing

Sustained GH/IGF-1 elevation

6-8 day half-life

Significant body composition changes

Community interest

This peptide is still gaining traction in the community.

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

CJC-1295 with DAC Molecular Information

View the scientifc details of CJC-1295 with DAC.

29

Amino Acids

CJC-1295 with DAC

Tyr

Tyr

Position 1

Ala

Ala

Position 2

Asp

Asp

Position 3

Ala

Ala

Position 4

Ile

Ile

Position 5

Phe

Phe

Position 6

Thr

Thr

Position 7

Gln

Gln

Position 8

Ser

Ser

Position 9

Tyr

Tyr

Position 10

Arg

Arg

Position 11

Lys

Lys

Position 12

Val

Val

Position 13

Leu

Leu

Position 14

Ala

Ala

Position 15

Gln

Gln

Position 16

Leu

Leu

Position 17

Ser

Ser

Position 18

Ala

Ala

Position 19

Arg

Arg

Position 20

Lys

Lys

Position 21

Leu

Leu

Position 22

Leu

Leu

Position 23

Gln

Gln

Position 24

Asp

Asp

Position 25

Ile

Ile

Position 26

Leu

Leu

Position 27

Ser

Ser

Position 28

Arg

Arg

Position 29

Amino acid sequence
TyrosinePosition 1
AlaninePosition 2
Aspartic acidPosition 3
AlaninePosition 4
IsoleucinePosition 5
PhenylalaninePosition 6
ThreoninePosition 7
GlutaminePosition 8
SerinePosition 9
TyrosinePosition 10
ArgininePosition 11
LysinePosition 12
ValinePosition 13
LeucinePosition 14
AlaninePosition 15
GlutaminePosition 16
LeucinePosition 17
SerinePosition 18
AlaninePosition 19
ArgininePosition 20
LysinePosition 21
LeucinePosition 22
LeucinePosition 23
GlutaminePosition 24
Aspartic acidPosition 25
IsoleucinePosition 26
LeucinePosition 27
SerinePosition 28
ArgininePosition 29

Molecular Weight

3367.9Da

Chain Length

29Amino Acids

Type

Peptide

CJC-1295 with DAC Protocols

Subcutaneous injection is the preferred route for DAC variant.

GoalDosageFrequencyRoute
Conservative Anti-Aging11 week rangeSubQ
Standard Protocol21 week rangeSubQ
Split Dosing12 week rangeSubQ
Loading Protocol2SubQ

Reconstitution Instructions

Materials needed:

CJC-1295 with DAC peptide vialBacteriostatic water (2-5mL)Insulin or 1mL syringesAlcohol prep pads

Steps to reconstitute

  1. Clean both vial tops with alcohol and dry completely
  2. 2mg vial: Add 1mL bacteriostatic water (creates 2mg/mL)
  3. 5mg vial: Add 2.5mL bacteriostatic water (creates 2mg/mL)
  4. Inject water slowly to prevent foaming
  5. Let sit 5 minutes before gently rolling to mix
  6. Solution may appear slightly cloudy initially
  7. Label with date and concentration immediately

CJC-1295 with DAC Cycle

The CJC-1295 with DAC Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Possible water retention, improved sleep, increased appetite
Week 2-3
Noticeable recovery improvements, some report joint discomfort
Week 4-6
Visible body composition changes, increased vascularity
Week 6-8
Continued improvements but watch for desensitization signs
Week 0-0
Most gains maintained; IGF-1 returns to baseline in 2-3 weeks

Dosing tools

CJC-1295 with DAC Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

CJC-1295 with DAC

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg CJC-1295 with DAC vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
CJC-1295 with DAC
Dosing
1-2mg weekly
Dosing Frequency
Once or twice weekly (e.g., Monday/Thursday for split dosing)
Cycle Duration
8-12 weeks
Storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of CJC-1295 with DAC interactions with other common peptides and substances.

Weight

cjc

Growth

CJC-1295 (without DAC)

AVOID

Never combine different variants; choose based on desired release pattern.

AVOID

Weight

ghrp

Growth

GHRP-6

MONITOR

GHRP pulse effects diminished with continuous GH elevation.

MONITOR

Weight

hgh

Growth

HGH

AVOID

Defeats purpose and may suppress natural production.

AVOID

Weight

ipa

Growth

Ipamorelin

MONITOR

Continuous GH elevation may reduce synergistic benefits of pulsatile protocols.

MONITOR

Weight

mk6

Growth

MK-677

AVOID

Both provide continuous GH elevation; combination risks excessive levels.

AVOID

Weight

ser

Growth

Sermorelin

MONITOR

CJC-1295 DAC is already more potent and long-lasting.

MONITOR

Weight

tesa

Growth

Tesamorelin

AVOID

Both are GHRH analogs; no additional benefit and potential receptor competition.

AVOID

Side effects

Avoid: Do not take CJC-1295 with DAC with CJC-1295 (without DAC), HGH, MK-677, Tesamorelin.

Monitor: Be careful when combining CJC-1295 with DAC with GHRP-6, Ipamorelin, Sermorelin.

Contraindications

Diabetes history

Cancer history

Predisposed sleep apnea

Stop signs

Severe joint pain or carpal tunnel syndrome

Excessive water retention affecting daily life

Numbness or tingling in extremities

Significant blood glucose dysregulation

Signs of acromegaly (jaw growth, hand/feet enlargement)

Persistent lethargy indicating adrenal effects

Bad signs

Extremely cheap pricing (if priced similar to non-DAC, likely mislabeled)Clear solution immediately (should be slightly cloudy initially)
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

CJC-1295 with DACResearch References

CJC-1295 with DAC is a well studied compound

4Research references

CJC-1295 with DAC

CJC-1295 with DAC is a well studied compound

Prolonged Growth Hormone Elevation with CJC-1295 DAC

12 subjects; sustained GH and IGF-1 elevation for 6-10 days post-injection with peak 2-4x baseline.

2006

Dose-Response Relationship of CJC-1295 DAC

48 subjects, 90 days. Optimal dosing 1-2mg weekly; dose-dependent IGF-1 increases but higher side effects above 2mg.

2008

Long-term Effects on GH/IGF-1 Axis

6-month animal model. Sustained IGF-1 elevation but evidence of reduced GH pulse amplitude suggesting desensitization.

2012

Comparative Pharmacokinetics: DAC vs Non-DAC Variants

DAC: 120-hour half-life vs non-DAC: 30-minute; non-DAC preserves more physiological patterns.

2015